US 6,789,038 C73

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instanceOf patent
gptkbp:applicationNumber 10/703,052
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,410,680_B2
gptkb:US_7,410,696_B2
gptkb:US_7,387,793_B2
gptkb:US_7,410,664_B2
gptkb:US_7,410,673_B2
gptkb:US_7,101,706_B2
gptkb:US_7,410,700_B2
gptkb:US_7,368,080_B2
gptkb:US_7,410,682_B2
gptkb:US_7,410,679_B2
gptkb:US_7,399,828_B2
gptkb:US_7,410,697_B2
gptkb:US_7,211,267_B2
gptkb:US_7,410,699_B2
gptkb:US_7,361,554_B2
gptkb:US_7,410,689_B2
gptkb:US_7,410,668_B2
gptkb:US_7,410,677_B2
gptkb:US_7,410,687_B2
gptkb:US_7,276,440_B2
gptkb:US_7,410,661_B2
gptkb:US_7,332,188_B2
gptkb:US_7,410,670_B2
gptkb:US_7,410,659_B2
gptkb:US_7,410,683_B2
gptkb:US_7,410,676_B2
gptkb:US_7,410,684_B2
gptkb:US_7,300,970_B2
US 7,410,691 B2
US_7,410,657_B2
US_7,410,658_B2
US_7,410,660_B2
US_7,410,662_B2
US_7,410,663_B2
US_7,410,665_B2
US_7,410,666_B2
US_7,410,667_B2
US_7,410,669_B2
US_7,410,671_B2
US_7,410,672_B2
US_7,410,674_B2
US_7,410,675_B2
US_7,410,678_B2
US_7,410,681_B2
US_7,410,685_B2
US_7,410,686_B2
US_7,410,688_B2
US_7,410,690_B2
US_7,410,692_B2
US_7,410,693_B2
US_7,410,694_B2
US_7,410,695_B2
US_7,410,698_B2
gptkbp:fieldOfInvention pharmaceuticals
https://www.w3.org/2000/01/rdf-schema#label US 6,789,038 C73
gptkbp:inventor gptkb:Robert_A._McCormick
gptkbp:issuedOn September 7, 2004
gptkbp:priorityDate March 29, 2001
gptkbp:relatedTo cancer treatment
gptkbp:status active
gptkbp:title Compositions and methods for treating cancer